awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34593276-DC081383-484D-4F21-B823-F2CF7BDAB8EC
Q34593276-DC081383-484D-4F21-B823-F2CF7BDAB8EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-DC081383-484D-4F21-B823-F2CF7BDAB8EC
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
P407
Q34593276-DC081383-484D-4F21-B823-F2CF7BDAB8EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-DC081383-484D-4F21-B823-F2CF7BDAB8EC
rank
NormalRank
type
BestRank
Statement
P407
English